Why do some life-saving AIDS medications cost 25 times more than their production price?

This video examines how patent-protected monopolies influence drug pricing. By comparing the U.S. market to countries like India, it illustrates the mechanics of market power and explains why the same essential medication can carry vastly different price tags depending on local patent laws.

Monopolies leverage market power to set prices significantly higher than the actual cost of production. A clear example is found in the U.S. market for AIDS medication, where patent rights grant manufacturers exclusive control, resulting in pill prices that are 25 times higher than their manufacturing cost.

In contrast, countries like India, which do not recognize patents for these specific drugs, maintain much lower prices. This disparity highlights the direct impact of legal protections on market competition and consumer affordability, showing how intellectual property frameworks can fundamentally alter the economic landscape for essential health resources.

Source: Maximizing Profit Under Monopoly